Rockwell Medical, Inc.
RMTI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001041024
No open-market purchases or sales by Rockwell Medical, Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Rockwell Medical, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +2 vs. Q3 2023
- Shares held
- 5.12M
- −70.3K (−1.4%) vs. Q3 2023
- Total value
- $9.68M
- −$1.12M (−10.4%) vs. Q3 2023
- New holders
- 8
- 12 more added
- Sold out
- 6
- 9 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RMTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 37 | $1.90M |
| Q1 2026 | 42 | $3.55M |
| Q4 2025 | 36 | $2.91M |
| Q3 2025 | 36 | $4.03M |
| Q2 2025 | 42 | $5.00M |
| Q1 2025 | 46 | $7.87M |
| Q4 2024 | 53 | $16.8M |
| Q3 2024 | 53 | $37.5M |
| Q2 2024 | 31 | $11.0M |
| Q1 2024 | 33 | $9.04M |
| Q4 2023 | 34 | $9.68M |
| Q3 2023 | 32 | $10.8M |
| Q2 2023 | 40 | $16.8M |
| Q1 2023 | 33 | $3.56M |
| Q4 2022 | 32 | $2.91M |
| Q3 2022 | 36 | $3.32M |
| Q2 2022 | 36 | $2.45M |
| Q1 2022 | 59 | $9.06M |
| Q4 2021 | 62 | $7.65M |
| Q3 2021 | 62 | $7.04M |
| Q2 2021 | 78 | $15.0M |
| Q1 2021 | 92 | $25.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Rockwell Medical, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,852,000 | $3.50M | 0.09% | −965,000−34.3% | Reduced |
| Vanguard Group Inc | 1,074,975 | $2.03M | 0.00% | +698,160+185.3% | Added |
| Richmond Brothers, Inc. | 412,433 | $779.5K | 1.36% | +2,081+0.5% | Added |
| Perkins Capital Management Inc | 349,934 | $661.0K | 0.56% | +274,891+366.3% | Added |
| Geode Capital Management, LLC | 283,923 | $536.7K | 0.00% | +40,915+16.8% | Added |
| Raymond James & Associates | 220,979 | $417.6K | 0.00% | +30,309+15.9% | Added |
| BlackRock Inc. | 178,201 | $336.8K | 0.00% | −354−0.2% | Reduced |
| Marshall Wace, LLP | 175,096 | $330.9K | 0.00% | −66,805−27.6% | Reduced |
| Renaissance Technologies LLC | 98,200 | $186.0K | 0.00% | +84,157+599.3% | Added |
| State Street Corp | 74,304 | $140.4K | 0.00% | +40,700+121.1% | Added |
| Northern Trust Corp | 63,838 | $120.7K | 0.00% | +106+0.2% | Added |
| Susquehanna International Group, LLP | 49,632 | $93.8K | 0.00% | −100,349−66.9% | Reduced |
| Two Sigma Investments, LP | 47,733 | $90.2K | 0.00% | +47,733 | New |
| HighTower Advisors, LLC | 32,698 | $62.0K | 0.00% | −22−0.1% | Reduced |
| Jane Street Group, LLC | 32,279 | $61.0K | 0.00% | +6,156+23.6% | Added |
| WealthTrust Axiom LLC | 31,500 | $59.5K | 0.02% | +10,400+49.3% | Added |
| Morgan Stanley | 26,463 | $50.0K | 0.00% | −7,496−22.1% | Reduced |
| Squarepoint Ops LLC | 24,522 | $46.3K | 0.00% | +24,522 | New |
| Citadel Advisors LLC | 23,841 | $45.1K | 0.00% | +23,841 | New |
| Great Valley Advisor Group, Inc. | 17,961 | $33.9K | 0.00% | 00.0% | Unchanged |
| SkyOak Wealth, LLC | 17,045 | $32.2K | 0.01% | −2,500−12.8% | Reduced |
| Cetera Advisor Networks LLC | 14,127 | $26.7K | 0.00% | 00.0% | Unchanged |
| Traphagen Investment Advisors LLC | 11,100 | $21.0K | 0.00% | +11,100 | New |
| Advisor Group Holdings, Inc. | 3,211 | $6.07K | 0.00% | −4,400−57.8% | Reduced |
| Tower Research Capital LLC (TRC) | 2,687 | $5.08K | 0.00% | +2,687 | New |
| Bank of America Corp | 1,990 | $3.76K | 0.00% | +92+4.8% | Added |
| Wells Fargo & Company | 809 | $1.53K | 0.00% | +11+1.4% | Added |
| Scarborough Advisors, LLC | 269 | $508 | 0.00% | +269 | New |
| Rise Advisors, LLC | 215 | $406 | 0.00% | 00.0% | Unchanged |
| Comerica Bank | 163 | $308 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 90 | $170 | 0.00% | −3,760−97.7% | Reduced |
| JPMorgan Chase & Co | 35 | $66 | 0.00% | 00.0% | Unchanged |
| Ogorek Anthony Joseph | 226 | $0 | 0.00% | +226 | New |
| Royal Bank of Canada | 115 | $0 | 0.00% | +115 | New |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −134,200−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −60,286−100.0% | Sold out |
| Sigma Investment Counselors Inc | 0 | $0 | 0.00% | −12,927−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Stonebridge Capital Advisors LLC | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |